117 related articles for article (PubMed ID: 24788963)
1. Sperm‑associated antigen 9 promotes astrocytoma cell invasion through the upregulation of podocalyxin.
Jiang J; Liu Y; Fang W; Liu F
Mol Med Rep; 2014 Jul; 10(1):417-22. PubMed ID: 24788963
[TBL] [Abstract][Full Text] [Related]
2. SPAG9 is overexpressed in human astrocytoma and promotes cell proliferation and invasion.
Yi F; Ni W; Liu W; Pan X; Han X; Yang L; Kong X; Ma R; Chang R
Tumour Biol; 2013 Oct; 34(5):2849-55. PubMed ID: 23696027
[TBL] [Abstract][Full Text] [Related]
3. Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide.
Wu H; Yang L; Liao D; Chen Y; Wang W; Fang J
Exp Ther Med; 2013 Apr; 5(4):1025-1029. PubMed ID: 23596468
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
5. Podocalyxin-like protein promotes gastric cancer progression through interacting with RUN and FYVE domain containing 1 protein.
Zhi Q; Chen H; Liu F; Han Y; Wan D; Xu Z; Kuang Y; Zhou J
Cancer Sci; 2019 Jan; 110(1):118-134. PubMed ID: 30407695
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.
Kusumoto H; Shintani Y; Kanzaki R; Kawamura T; Funaki S; Minami M; Nagatomo I; Morii E; Okumura M
Cancer Sci; 2017 Mar; 108(3):528-535. PubMed ID: 28004467
[TBL] [Abstract][Full Text] [Related]
7. Radiation-Induced Overexpression of TGFβ and PODXL Contributes to Colorectal Cancer Cell Radioresistance through Enhanced Motility.
Lee H; Kong JS; Lee SS; Kim A
Cells; 2021 Aug; 10(8):. PubMed ID: 34440856
[TBL] [Abstract][Full Text] [Related]
8. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
9. Podocalyxin-like 1 is associated with tumor aggressiveness and metastatic gene expression in human oral squamous cell carcinoma.
Lin CW; Sun MS; Wu HC
Int J Oncol; 2014 Aug; 45(2):710-8. PubMed ID: 24821609
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis.
Miao ZF; Wang ZN; Zhao TT; Xu YY; Wu JH; Liu XY; Xu H; You Y; Xu HM
Virchows Arch; 2015 Nov; 467(5):525-33. PubMed ID: 26293216
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and biological roles of SPAG9 overexpression in non-small cell lung cancer.
Wang Y; Dong Q; Miao Y; Fu L; Lin X; Wang E
Lung Cancer; 2013 Aug; 81(2):266-72. PubMed ID: 23711689
[TBL] [Abstract][Full Text] [Related]
12. SPAG9/MKK3/p38 axis is a novel therapeutic target for liver cancer.
Luo S; Ren B; Zou G; Liu J; Chen W; Huang Y; Chen X; Fu Y
Oncol Rep; 2019 Apr; 41(4):2329-2336. PubMed ID: 30720101
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin.
Taniuchi K; Furihata M; Naganuma S; Dabanaka K; Hanazaki K; Saibara T
Cancer Sci; 2016 Oct; 107(10):1430-1442. PubMed ID: 27461278
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of microRNA-5100 decreases the aggressive phenotype of pancreatic cancer cells by targeting PODXL.
Chijiiwa Y; Moriyama T; Ohuchida K; Nabae T; Ohtsuka T; Miyasaka Y; Fujita H; Maeyama R; Manabe T; Abe A; Mizuuchi Y; Oda Y; Mizumoto K; Nakamura M
Int J Oncol; 2016 Apr; 48(4):1688-700. PubMed ID: 26892887
[TBL] [Abstract][Full Text] [Related]
15. High Podocalyxin levels promote cell viability partially through up-regulation of Annexin A2.
San IV; Prost G; Williams JA; Moss SE; Nuber UA
Biochem Biophys Res Commun; 2016 Sep; 478(2):573-9. PubMed ID: 27470587
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA-mediated down-regulation of SPAG9 inhibits cervical tumor growth.
Garg M; Kanojia D; Suri S; Suri A
Cancer; 2009 Dec; 115(24):5688-99. PubMed ID: 19813278
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy.
Snyder KA; Hughes MR; Hedberg B; Brandon J; Hernaez DC; Bergqvist P; Cruz F; Po K; Graves ML; Turvey ME; Nielsen JS; Wilkins JA; McColl SR; Babcook JS; Roskelley CD; McNagny KM
Breast Cancer Res; 2015 Mar; 17(1):46. PubMed ID: 25887862
[TBL] [Abstract][Full Text] [Related]
18. SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis in vitro.
Chen F; Lu Z; Deng J; Han X; Bai J; Liu Q; Xi Y; Zheng J
Oncol Rep; 2014 Dec; 32(6):2533-40. PubMed ID: 25310386
[TBL] [Abstract][Full Text] [Related]
19. Eya2 overexpression promotes the invasion of human astrocytoma through the regulation of ERK/MMP9 signaling.
Wen Z; Liang C; Pan Q; Wang Y
Int J Mol Med; 2017 Nov; 40(5):1315-1322. PubMed ID: 28901379
[TBL] [Abstract][Full Text] [Related]
20. Podocalyxin promotes glioblastoma multiforme cell invasion and proliferation by inhibiting angiotensin-(1-7)/Mas signaling.
Liu B; Liu Y; Jiang Y
Oncol Rep; 2015 May; 33(5):2583-91. PubMed ID: 25708368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
